Healthtech Startups

VascAI provides an AI platform for healthcare care teams that automates clinical workflows including triage, documentation, and patient follow-up through voice agents and treatment co-pilots. The platform is designed to reduce administrative burden, improve patient outcomes, and lower costs for chronic care management.

1 investor

Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.

1 investor

VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.

1 investor

Vastian provides a platform that helps hospital and laboratory professionals manage quality standards, competency assessments, and equipment sanitation policies. The company serves independent lab organizations and large health systems across the United States and globally.

1 investor

Vave Health develops portable, affordable ultrasound imaging technology aimed at clinicians and healthcare providers, including those serving underserved areas. Its products are used in settings such as medical schools for integrating ultrasound into training.

1 investor

VaxCheck is an algorithm-driven clinical decision aid that helps pharmacists identify vaccination gaps and public funding eligibility for adult patients without requiring a prior vaccine record. It is aimed at community pharmacies in Canada, currently supporting pharmacy scope of practice in Ontario with other provinces in development.

1 investor

VAXIMM is a clinical-stage biopharmaceutical company developing oral T-cell immunotherapies for cancer, based on technology invented at UC San Diego. Its lead candidate VXM01 has been evaluated in clinical trials for indications such as pancreatic cancer, and the company operates as a subsidiary of OSR Health.

1 investor

VBA provides a suite of software for administering health benefits, including a core platform for managing multiple lines of business, member web and mobile portals, analytics, APIs, and healthcare data management services. Its solutions serve health plans and benefits administrators, handling functions such as claims auto-adjudication, plan builds, and EDI data transfers.

1 investor

VBI Vaccines is a biopharmaceutical company developing vaccine candidates using virus-like particle (VLP) platforms, including proprietary enveloped VLP and mRNA-launched eVLP technologies. It targets infectious diseases such as hepatitis B, COVID-19, and cytomegalovirus, as well as cancers including glioblastoma.

1 investor

VB Spine develops spinal surgery systems, instrumentation, and surgeon education programs, serving spine surgeons and their patients. It operates in the medical device industry with a product portfolio and clinical resources focused on spine surgery.

1 investor

VCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.

1 investor

VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.

1 investor

VEA builds AI-based software for veterinary practices, including diagnostic tools and practice management workflows. It serves veterinary professionals and teams in the pet care industry.

1 investor

Veba is a device that monitors and tracks breast milk and formula through automated temperature, time, and feeding tracking, sending expiration alerts to parents and caregivers.

1 investor

Vectech develops AI-powered vector identification and surveillance technologies to support public health interventions and targeted mosquito control during disease outbreaks. The company serves public health organizations and disease prevention agencies globally.

1 investor

Vedana Therapeutics develops next-generation biologic medicines for migraine prevention, targeting PACAP and CGRP-independent pathways to address unmet needs in patients inadequately controlled by current therapies. The company focuses on the neurological and pharmaceutical sectors to serve the global migraine patient population.

1 investor

Beidenmedical is a medical device supplier and distributor serving healthcare dealers and partners in China, operating a digital supply and services platform for medical equipment distribution.

1 investor

Vedi is a vet-tech company providing electronic health records for veterinary care, linking an animal's medical information to their microchip so records follow the pet across clinics, labs, shelters and owners. It serves veterinarians, clinics and pet owners, and connects to labs and microchip registries to reduce admin and data-entry errors.

1 investor

Vee Healthtek provides revenue cycle management and AI-driven automation solutions for healthcare providers and payers. The company helps healthcare organizations optimize financial performance and operational efficiency through intelligent automation and data-driven innovation.

1 investor

Vega Health helps health systems evaluate, implement, monitor, and scale third-party AI solutions across their organizations, focusing on last-mile implementation and objective performance monitoring. It serves healthcare delivery organizations, acting as a vendor-neutral partner sourcing validated clinical and operational AI tools.

1 investor

VEGAIN produces plant-based sports nutrition products designed for athletic performance and fitness, positioning themselves as a sustainable alternative to animal-based options. The company is Canadian-based and emphasizes clean formulations, scientific backing, and environmental responsibility.

1 investor

VeinCentre is a UK medical provider specialising in the diagnosis and treatment of varicose veins, venous leg ulcers, and facial thread veins using minimally invasive, walk-in walk-out procedures. Operating over 40 clinics nationwide, it serves patients seeking vein care and is the country's largest dedicated vein specialist.

1 investor

Veirulence develops first-in-class non-antibiotic small molecule therapeutics that target bacterial virulence factors to treat resistant infections, with an initial focus on the WHO priority pathogen Pseudomonas aeruginosa. The company aims to address antimicrobial resistance in hospital-acquired bacterial infections.

1 investor

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.

1 investor